SK Biopharmaceuticals Co., Ltd. (KRX:326030)
134,000
-2,300 (-1.69%)
At close: Dec 5, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 10.49 trillion as of December 5, 2025. Its market cap has increased by 19.64% in one year.
Market Cap
10.49T
Enterprise Value
10.30T
Revenue
675.41B
Ranking
n/a
PE Ratio
32.75
Stock Price
134,000.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has increased from 9.95T to 10.49T, an increase of 5.51%. That is a compound annual growth rate of 0.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 10.49T | 20.61% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.30T |
| ALTEOGEN | 27.86T |
| ABL Bio | 11.08T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,907.33B |
| Peptron | 6,668.76B |
| HLB Co., Ltd. | 6,394.65B |